Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-10
1995-05-30
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
054201357
ABSTRACT:
Substituted quinoline derivatives are described as inhibitors bone resorption with in particular, the compound 1-(2-methylphenyl)imidazo[4,5-c]quinoline hydrochloride.
REFERENCES:
patent: 4689338 (1987-08-01), Gerster
T. Brown et al., J. Med. Chem. 1990, 33, 527-533.
Brown Thomas H.
Ife Robert J.
Keeling David J.
Leach Colin A.
Hall Linda E.
Henley III Raymond
Lentz Edward T.
Smith Kline & French Laboratories Limited
Spivack Phyllis G.
LandOfFree
Substituted quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362038